These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1534983)

  • 1. [Effect of high-dose medroxyprogesterone acetate on coagulative and fibrinolytic factors in patients with gynecological cancers].
    Ishizaki T; Itoh R; Yasuda J; Yamamoto T; Okada H
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):837-42. PubMed ID: 1534983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The medroxyprogesterone acetate serum level following various medroxyprogesterone acetate dose schedules in gynecologic oncology].
    Husslein P; Egarter C; Eppel W; Salzer H; Spona J
    Zentralbl Gynakol; 1988; 110(20):1277-82. PubMed ID: 2977043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of high-dose medroxyprogesterone acetate (HD-MPA) on hematological toxicity induced by chemotherapy for advanced solid tumors: a multicentric controlled clinical trial. MPA-Hematology Italian Cooperative Group.
    Chemioterapia; 1986 Apr; 5(2):134-9. PubMed ID: 2871945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in hematologic parameters during treatment with medroxyprogesterone acetate for breast cancer.
    Yamamoto H; Noguchi S; Miyauchi K; Inaji H; Imaoka S; Koyama H; Iwanaga T
    Jpn J Cancer Res; 1991 Apr; 82(4):420-5. PubMed ID: 1828463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
    Uchida Y
    Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause.
    Perrone G; Capri O; Galoppi P; Brunelli R; Bevilacqua E; Ceci F; Ciarla MV; Strom R
    Gynecol Obstet Invest; 2009; 68(1):33-9. PubMed ID: 19349712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of medroxyprogesterone acetate therapy on advanced or recurrent breast cancer and its influences on blood coagulation and the fibrinolytic system.
    Abe O; Asaishi K; Izuo M; Enomoto K; Koyama H; Tominaga T; Nomura Y; Ohshima A; Aoki N; Tsukada T
    Surg Today; 1995; 25(8):701-10. PubMed ID: 8520164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK; Mestries JC; Gascon MP; Ythier A
    Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever.
    Heller MV; Marta RF; Sturk A; Maiztegui JI; Hack CE; Cate JW; Molinas FC
    Thromb Haemost; 1995 Mar; 73(3):368-73. PubMed ID: 7667817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of medroxyprogesterone acetate on side effects of CAP therapy in gynecological malignant tumors].
    Yanagawa Y; Okazaki T; Okamura S; Ueki M; Sugimoto O
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2393-8. PubMed ID: 2526618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chemoendocrine therapy on the coagulation-fibrinolytic systems in patients with advanced breast cancer. Japan Advanced Breast Cancer Study Group and Japan Clinical Oncology Group.
    ;
    Jpn J Cancer Res; 1993 Apr; 84(4):455-61. PubMed ID: 8514613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination estrogen and progestogen replacement therapy does not adversely affect coagulation.
    Notelovitz M; Kitchens C; Ware M; Hirschberg K; Coone L
    Obstet Gynecol; 1983 Nov; 62(5):596-600. PubMed ID: 6621949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic effects of high-dose megestrol acetate therapy in patients with advanced gynecological cancer.
    Oberhoff C; Hoffmann O; Winkler UH; Schindler AE
    Gynecol Endocrinol; 2001 Oct; 15(5):341-8. PubMed ID: 11727356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
    Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.